TRNS TRANSCAT INC
Instruments For Meas & Testing of Electricity & Elec Signals · Nasdaq · SEC CIK 99302 · Fiscal year ends 03/27
Financial factors as of 2026-03-28 (FY2026), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY19.2%
TTM net income YoY-63.0%
TTM EPS YoY-63.7%
Revenue 3-yr CAGR12.9%
Net income 3-yr CAGR-20.5%
Margins
Gross margin32.6%
Operating margin4.0%
Net margin1.6%
FCF margin5.9%
EBITDA margin11.9%
Returns
ROE1.8%
ROA1.2%
ROIC (approx.)2.5%
Asset turnover0.77x
Leverage & solvency
Liabilities / assets37.4%
Debt / equity0.33x
Current ratio2.33x
Interest coverage2.88x
Cash quality & payout
Operating cash flow / net income6.48x
Accruals ratio-6.8%
Payout ratio—
Capex / revenue4.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-28 | FY20252025-03-29 | FY20242024-03-30 | FY20232023-03-25 | FY20222022-03-26 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $331.88M | $278.42M | $259.48M | $230.57M | $204.96M |
| Cost of revenue | $223.57M | $188.97M | $175.68M | $162.21M | $146.52M |
| Gross profit | $108.30M | $89.45M | $83.81M | $68.36M | $58.44M |
| SG&A expense | $52.28M | $38.24M | $35.31M | $27.35M | $23.65M |
| Operating income | $13.26M | $17.87M | $19.78M | $16.25M | $14.14M |
| Interest expense | $4.60M | $798,000 | $1.83M | $2.42M | $810,000 |
| Pretax income | $7.99M | $18.33M | $18.44M | $13.49M | $13.19M |
| Income tax | $2.61M | $3.81M | $4.79M | $2.80M | $1.81M |
| Net income | $5.38M | $14.52M | $13.65M | $10.69M | $11.38M |
| EBITDA | $39.44M | $36.44M | $33.33M | $27.20M | $23.71M |
| EPS (basic) | 0.58 | 1.58 | 1.66 | 1.42 | 1.52 |
| EPS (diluted) | 0.57 | 1.57 | 1.63 | 1.40 | 1.50 |
| Weighted avg. shares (diluted) | 9.38M | 9.25M | 8.35M | 7.64M | 7.59M |
| Balance sheet | |||||
| Cash & equivalents | $4.94M | $1.52M | $19.65M | $1.53M | $1.40M |
| Short-term investments | — | $0 | $15.53M | $0 | — |
| Receivables | $65.17M | $55.94M | $47.78M | $44.70M | $39.74M |
| Inventory | $13.71M | $14.48M | $17.42M | $16.93M | $12.71M |
| Current assets | $92.46M | $78.01M | $105.16M | $67.60M | $59.70M |
| PP&E, net | $57.80M | $50.02M | $38.94M | $29.06M | $26.44M |
| Goodwill | $218.19M | $176.93M | $105.58M | $69.36M | $65.07M |
| Intangibles | $77.71M | $54.78M | $19.99M | $13.80M | $14.69M |
| Total assets | $480.49M | $385.24M | $287.55M | $195.75M | $177.76M |
| Current liabilities | $39.63M | $34.04M | $33.50M | $28.32M | $27.71M |
| Short-term debt | $0 | $1.82M | $2.34M | $2.25M | $2.16M |
| Long-term debt | $99.89M | $30.89M | $1.82M | $46.87M | $46.29M |
| Total debt | $99.89M | $32.71M | $4.16M | $49.12M | $48.45M |
| Total liabilities | $179.87M | $98.36M | $62.38M | $96.12M | $91.59M |
| Shareholders' equity | $300.62M | $286.88M | $225.17M | $99.63M | $86.18M |
| Net debt | $94.94M | $31.19M | -$15.49M | $47.59M | $47.06M |
| Shares outstanding | 9.33M | 9.32M | 8.84M | 7.56M | 7.53M |
| Cash flow statement | |||||
| Operating cash flow | $34.85M | $38.98M | $32.62M | $16.95M | $17.62M |
| Capital expenditure | $15.30M | $13.20M | $13.28M | $9.41M | $10.15M |
| Free cash flow | $19.55M | $25.79M | $19.34M | $7.54M | $7.47M |
| Investing cash flow | -$97.82M | -$84.00M | -$41.67M | -$18.51M | -$39.85M |
| Financing cash flow | $66.50M | $26.86M | $27.40M | $876,000 | $23.69M |
| Depreciation & amortization | $26.17M | $18.57M | $13.54M | $10.96M | $9.57M |
| Stock-based compensation | $7.55M | $3.25M | $4.51M | $3.38M | $2.33M |
| Share buybacks | $469,000 | $3.56M | $4.91M | $447,000 | $6.68M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.